Keywords: شیمی درمانی; Chemoimmunotherapy; Cytotoxic drugs; Galectin-9; Programmed cell death ligand-1; Subtype; Triple-negative breast cancer;
مقالات ISI شیمی درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شیمی درمانی; Follicular lymphoma; Early therapy failure; Autologous transplantation; Early transplant; Rituximab; Chemoimmunotherapy;
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Population-based; Treatment; Survival; FISH; Chemoimmunotherapy;
Keywords: شیمی درمانی; Chemoimmunotherapy; Oxaliplatin; Immune checkpoints; Colorectal cancer; Tumor regression;
Keywords: شیمی درمانی; Hepatocellular cancer (HCC); Chemoimmunotherapy; Regulatory T cells (Tregs); Programmed cell death protein 1 (PD-1); Sunitinib; Cancer; Circulating tumor cell (CTC); Immune checkpoint;
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Choice of therapy; Chemoimmunotherapy; Kinase inhibitors;
Keywords: شیمی درمانی; Anthracyclines; Doxorubicin; Anticancer immunity; Immunomodulation; Chemoimmunotherapy;
Keywords: شیمی درمانی; Anticancer therapy; Anti-CD20; Chemoimmunotherapy; Haematological toxicity; Secondary effects
Keywords: شیمی درمانی; Bendamustine; BR; Chemoimmunotherapy; CLL; FCR
Keywords: شیمی درمانی; Hairy cell leukaemia; Purine analogue; Pentostatin; Cladribine; Rituximab; Chemoimmunotherapy; Survival;
Keywords: شیمی درمانی; B2M; beta 2 microglobulin; CAR; cyclophophamide, alvocidib, rituximab; CDK; cyclin-dependent kinase; CLL; chronic lymphocytic leukemia; CR; complete response; CRS; cytokine release syndrome; DLT; dose limiting toxicity; ECOG; Eastern Cooperative Oncology
The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma
Keywords: شیمی درمانی; Diffuse large B-cell lymphoma; Neutrophil:lymphocyte ratio; Chemoimmunotherapy; Response; Progression-free survival; Overall survival;
OncologyChemoimmunotherapeutic effect of combined treatment with ex vivo generated antigen-presenting immune cells and conventional antitumor agents in a mouse neuroblastoma model
Keywords: شیمی درمانی; GM-CSF; granulocyte-macrophage colony stimulating factor; IL-4; interleukin-4; CpG-ODN; CpG-oligodeoxynucleotide; BMDA; bone marrow-derived adherent cells; Neuroblastoma; Anticancer agent; Antitumor immunity; Cell therapy; Chemoimmunotherapy; Immunogenic
New treatment approaches in CLL: Challenges and opportunities in the elderly
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Chemoimmunotherapy; Kinase inhibitors; BCL2 inhibitor;
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
Keywords: شیمی درمانی; Anti-CD20 monoclonal antibody; Chemoimmunotherapy; DLBCL; Non-Hodgkin lymphoma; R-CHOP;
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma
Keywords: شیمی درمانی; Chemoimmunotherapy; Follicular lymphoma; Immunomodulation; Immunotherapy; Pilot study
Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy
Keywords: شیمی درمانی; Chemoimmunotherapy; Diffuse large B-cell lymphoma; Dog; Lymphocyte-monocyte ratio; Prognosis;
Chemoimmunotherapy for hairy cell leukemia
Keywords: شیمی درمانی; Hairy cell leukemia; Nucleoside analogs; Rituximab; Chemoimmunotherapy;
Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms
Keywords: شیمی درمانی; Chemoimmunotherapy; Non-Hodgkin lymphoma; Prognosis; Rituximab; Systematic review;
Chronic Lymphocytic Leukemia With Central Nervous System Involvement: A High-Risk Disease?
Keywords: شیمی درمانی; Central nervous system; Chemoimmunotherapy; Chronic lymphocytic leukemia; Leptomeningeal dissemination; Neurologic involvement;
Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
Keywords: شیمی درمانی; DLBCL; Race; Rituximab; Chemoimmunotherapy; R-CHOP
Improving the Treatment Outcome of Patients with Chronic Lymphocytic Leukemia Through Targeted Antibody Therapy
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Monoclonal antibody; Immunotherapy; Chemoimmunotherapy; Antibody;
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Rituximab; Dexamethasone; Refractory disease; Chemoimmunotherapy; Corticosteroids;
Bortezomib (Velcade), Rituximab, Cyclophosphamide, and Dexamethasone Combination Regimen Is Active as Front-Line Therapy of Low-Grade Non-Hodgkin Lymphoma
Keywords: شیمی درمانی; Chemoimmunotherapy; Low-grade lymphoma; Rituximab; Velcade
Optimal management of older patients with chronic lymphocytic leukemia: Some facts and principles guiding therapeutic choices
Keywords: شیمی درمانی; Chronic lymphocytic leukemia (CLL); Elderly; Old; Therapy; Chemoimmunotherapy; Clinical trials; Rituximab; Purine analogs; Fludarabine
An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human glioma cells
Keywords: شیمی درمانی; Glioma; Transferrin receptor; Monoclonal antibody; Nimustine; Chemoimmunotherapy;
State of the art treatment of chronic lymphocytic leukaemia
Keywords: شیمی درمانی; Chronic lymphocytic leukaemia (CLL); Therapy; Treatment; Chemoimmunotherapy; Monoclonal antibodies
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years
Keywords: شیمی درمانی; Chronic lymphocytic leukemia (CLL); Chemoimmunotherapy; Mitoxantroe; Nucleoside analogs
Role of CD20 Monoclonal Antibodies in Previously Untreated Chronic Lymphocytic Leukemia
Keywords: شیمی درمانی; Alemtuzumab; Bendamustine; Chemoimmunotherapy; Chlorambucil; Cyclophosphamide; Fludarabine; Mitoxantrone; Pentostatin; Rituximab
Interleukin-21 restrains tumor growth and induces a substantial increase in the number of circulating tumor-specific T cells in a murine model of malignant melanoma
Keywords: شیمی درمانی; Interleukin-21; Cyclophosphamide; Chemoimmunotherapy; Adoptive cell transfer; Malignant melanoma
Monoclonal antibody therapy of chronic lymphocytic leukaemia
Keywords: شیمی درمانی; monoclonal antibody; rituximab; alemtuzumab; ofatumumab; chemoimmunotherapy
An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells
Keywords: شیمی درمانی; Transferrin receptor; Monoclonal antibody; Chemotherapeutic drug; Chemoimmunotherapy; Non-hematopoietic tumor cells
Controversies in the front-line management of chronic lymphocytic leukemia
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Chemoimmunotherapy; Front-line therapy
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
Keywords: شیمی درمانی; Chronic lymphocytic leukemia (CLL); TCL-1; Prognostic factor; Pentostatin; Chemoimmunotherapy
Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia
Keywords: شیمی درمانی; p53; ATM; interphase cytogenetics; chemoimmunotherapy; alemtuzumab; corticosteroids; stem-cell transplant; CD40; flavopiridol;
Recent progress in the management of chronic lymphocytic leukemia
Keywords: شیمی درمانی; Chronic lymphocytic leukemia; Purine nucleoside analogs; Fludarabine; Cladribine; Pentostatin; Rituximab; Alemtuzumab; Chemoimmunotherapy; Monoclonal antibodies; Stem cell transplantation
Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Researc
Keywords: شیمی درمانی; Chemoimmunotherapy; Dacarbazine monotherapy; Cisplatin; Interferon-alpha; Interleukin-2; Metastatic melanoma
Combined chemoimmunotherapy of solid tumours: Improving vaccines?
Keywords: شیمی درمانی; Immunotherapy; Antineoplastic agents; Tumour vaccines; Tumour antigen; Chemoimmunotherapy